Comparison of catecholamine release in the isolated adrenal glands of SHR and WKY rats

Autonomic and Autacoid Pharmacology

Volumn 22, Issue 4, 2002, Pages 225-232

  Lim, D Y ^a   Jang, S J ^a   Park, D G ^a  

^a Chosun University   (South Korea)

Author keywords

Adrenal gland; Catecholamine secretion; Hypertensive pathogenesis; SHR; WKY rats

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; 1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (CALCIUM) INHIBITOR; CALCIUM CHANNEL; CALCIUM CHANNEL STIMULATING AGENT; CATECHOLAMINE; CHOLINERGIC RECEPTOR; CYCLOPIAZONIC ACID; DIHYDROPYRIDINE DERIVATIVE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; NICOTINIC AGENT; NICOTINIC RECEPTOR; POTASSIUM; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ADRENAL FUNCTION; ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG SELECTIVITY; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; INHIBITION KINETICS; ISOLATED ORGAN; MALE; MEMBRANE DEPOLARIZATION; NONHUMAN; ORGAN WEIGHT; PATHOGENESIS; POTASSIUM TRANSPORT; RAT; RAT STRAIN; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; SPONTANEOUSLY HYPERTENSIVE RAT; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE; TISSUE PERFUSION;

ADRENAL GLANDS; ANIMALS; CATECHOLAMINES; CHOLINERGIC AGONISTS; HYPERTENSION; MALE; PERFUSION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, CHOLINERGIC;

EID: 0038516497     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1474-8673.2002.00264.x     Document Type: Article

References (53)

1. ADAMS, M.A., BOBIK, A. & KORNER, P.I. (1989). Differential development of vascular and cardiac hypertrophy in genetic hypertension. Hypertens. Res., 14, 191-202.
2. ANTON, A.H. & SAYRE, D.F. (1962). A study of the factors affecting the aluminum oxide trihydroxy indole procedure for the analysis of catecholamines. J. Pharmacol. Exp. ther., 138, 360-375.
3. BRISAC, A.M., HUGUET, F., CHAMPEROUX, P., MONTASTRUC, J.L., LUCET, B., GERARD, P., LAURENT, S., NARCISSE, G. & SCHMITT, H. (1987). Central interactions between dihydropyridines and cholinergic systems in the control of blood pressure in rat. Brain Res., 435, 160-166.
4. BUNAG, R.D. & EFERAKEYA, A.E. (1976). Immediate hypotensive after-effects of posterior hypothalamic lesions in awake rats with spontaneous, renal and DOCA hypertension. Cardiovasc. Res., 10, 663-671.
5. CASSIS, L.A., STITZEL, R.E. & HEAD, R.J. (1985). Hypernor- adrenergic innervation of the caudal artery of the spontaneously hypertensive rat: an influence upon neuroeffector mechanisms. J. Pharm. Exp. ther., 234, 792-803.
6. DEVINE, C.E., SOMLYO, A.V. & SOMLYO, A.P. (1972). Sarcoplasmic reticulum and excitation-contraction coupling in mammalian smooth muscle. J. Cell. Biol., 52, 690-718.
7. DU, G.G., ASHLEY, C.C. & LEA, T.J. (1994). Effects of thapsigargin and cyclopiazonic acid on the sarcoplasmic reticulum Ca2+ pump of skinned fibers from frog skeletal muscle. Pflügers Arch., 42, 169-175
8. DU, G.G., ASHLEY, C.C. & LEA, T.J. (1996). Ca2+ e81uxes from the sarcoplasmic-reticulum vesicles of hog-muscle. effects of cyclopiazonic: acid and thapsigargin. Cell Calcium, 20, 355-359.
9. FOLKOW, B. (1982). Physiological aspects of primary hypertension. Physiol. Rev., 62, 347-504.
10. FOLKOW, B., HALLBACK, M., LUNDGREN, Y. & WEISS, L. (1970). Background of increased flow resistance and vascular design for establishment of primary hypertension studied in man and in spontaneously hypertensive rats. Circ. Res., 82 (Suppl 1),I 2-I 13.
11. FOLKOW, B. & KARLSTROM, G. (1984). Age and pressure- dependent changes of systemic resistance vessels concerning the relationships between geometric design, wall distensibility, vascular reactivity and smooth muscle sensitivity. Acta Physiol. Scand., 122, 17-34.
12. GARCIA, A.G., SALA, F., REIG, J.A., VINIEGRA, S., FRIAS, J., FONTERIZ, R. & GANDIA, L. (1984). Dihydropyridine BAY-K-8644 activates chromaffin cell calcium channels. Nat. Genet., 309, 69-71.
13. GOLDSTEIN, D.S. (1981). Plasma norepinephrine in essential hypertension. A study of the studies. Hypertens. Res., 3, 48-52.
14. GROLDSTEINS, D.S. (1983). Arterial baroreflect sensitivity, plasma catecholamine and pressor reponsiveness in essential hypertension. Circ. Res., 68, 234-240.
15. 2+ permeability. Biochem. Pharmacol., 38, 3995-4003.
16. GRADIN, J., NISSBRAND, H., EGRENSTROM, F., HENNING, M. & TERSSON, B. (1988). Adrenergic mechanisms during hypertension induced by sucrose and/or salt in the spontaneously hypertensive rat. Naunyn Schmiedebergs Arch. Pharmacol., 337, 47-52.
17. GROBECKER, G., ROIZEN, G., M.F., WEISE, V., SAAREDRA, J.M. & KOPIN, I.J. (1975). Letter: sympathadrenal medullary activity in young, spontaneously hypertensive rats. Nat. Genet., 258, 267-268.
18. 2 biochemical and functional characterization. Life Sci., 31, 2992-2998.
19. 3H](+)-PN200-100 binding. Brain Res., 412, 125-130.
20. HUTCHET, C. & LEOTY, C. (1994). Effect of cyclopiazonic acid on contractile responses in slow and fast bundles of cremaster skeletal muscle from the ferret. Can. J. Physiol. Pharmacol., 72, 833-839
21. IRIUCHIJIMA, J. (1973). Sympathetic discharge rate in spontaneously hypertensive rats. Jpn. Heart J., 14, 350-356.
22. 3H]nitrendipine to cardiac and cerebral membranes from normotensive and renal, deoxycorticosterone/ NaCl and spontaneously hypertensive rats. Eur. J. Pharmacol., 123, 271-278.
23. JUDY, W.V., WATANABE, A.M., HENRY, D.P., BESCH, N.R. Jr, MURPHY, W.R. & HOCKEL, G.M. (1976). Sympathetic nerve activity: role in regulation of blood pressure in the spontaneously hypertensive rat. Circ. Res., 38 (Suppl. 2), 21-29.
24. KIHARA, M., HORIE, R., LOVENBERG, W. & YAMORI, Y. (1993). Comparative study of various genetic hypertensive rat strains: blood pressure, body weight, growth and organ weights. Heart Vessels, 8, 7-15.
25. KLEMOLA, R., HUTTUNER, P., LAINE, M., WECKSTROM, M. & HIRVONEN, J. (1999). Catecholamines in pericardial fluid of normotensive, spontaneously hypertensive and reserpine-treated rats. Acta Physiol. Scand. 165, 293-297.
26. KLINE, R.L., KELTON, P.M. & MERCER, P.F. (1978). Effect of renal denervation on the development of hypertension in spontaneously hypertensive rats. Can. J. Physiol. Pharmacol., 56, 818-822.
27. KUREBAYASHI, N. & OGAWA, Y. (1991). Discrimination of calcium-ATPase activity of the sarcoplasmic reticulum from actomyosin-type ATPase activity in skinned mammalian skeletal muscle fibers: distinct effects of cyclopiazonic acid on the two ATPase activities. J. Muscle Res. Cell Motil., 12, 355-365.
28. LAIS, L.T., BRODYS, M.J., BHATNAGAR, R. & ROSKOSKI, R. (1976). Evidence that hypertension appears in SHR in the absence of altered sympathetic nervous system activity or development. In: Spontaneous Hypertension: Its Pathogenesis and Complication, pp. 237-246. DHEW Publication (No. NIH 77-1179). National Institutes of Health, Bethesda, MD.
29. LAURENT, S., GRERD, X., TSOUKARIS-KUPFER, D., LEGRAND, M., HUCHET-BRISAC, A.M. & SCHMITT, H. (1987). Opposite central cardiovascular effects of nifedipine and Bay K 8644 in anesthetized rats. Hypertens. Res., 9, 132-138.
30. LIARD, J.F. (1977). Renal denervation delays blood pressure increase in the spontaneously hypertensive rat. Experientia, 33, 339-340.
31. LIM, D.Y., KIM, C.D. & AHN, K.W. (1992). Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch. Pharm. Res., 15, 115-125.
32. MAARSHALL, J.M. (1982). The influence of the sympathetic nervous system on individual vessels of the microcirculation of skeletal muscle of the rat. J. Physiol., 332, 169-186.
33. MASPERS, M., BJOMBERG, J., GRAND, P.O. & MELLANDER, S. (1990). Sympathetic-adrenergic cintrol of large-bore arterial vessels, arterioles and veins and of capillary pressure and fluid exchange in whole-organ cot skeletal muscle. Acta Physiol. Scand., 138, 509-521.
34. MULVANY, M.J., NILSON, H., NYBORG, N. & MIKKELSEN, Z. (1982). Are isolated femoral resistance vessels or tail arteries good models for the hindquarter vasculature of spontaneously hypertensive rats? Acta Physiol. Scand., 116, 275-283.
35. MULVANY, M.J., BAANDRUP, U. & GUNDERSEN, H.J.G. (1985). Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional dessector. Circ. Res., 57, 794-800.
36. NILSSON, H., JENSEN, P.E. & MULVANY, M.J. (1994). Minor role for direct adrenoceptor-mediated calcium entry in rat mesenteric small arteries. J. Vasc. Res., 31, 314-321.
37. O'CONNOR, D.T., TAKIYYUDDIN, M.A., PRINTZ, M.P. et al. (1999). Catecholamine storage vesicle protein expression in genetic hypertension. Blood Press., 8, 285-295.
38. PAK, C.H. (1981). Plasma adrenaline and noradrenaline concentrations of the spontaneously hypertensive rat. Jpn. Heart J., 22, 987-995.
39. RODIONOV, I.M., TARASOVA, O.S., VAKULINA, T.P., KOSHELER, V.B., PINELIS, V.G. & MARKOV, CH.M. (1992). Vasoconstrictor reactions in spontaneously hypertensive rats vs. Wistar Kyoto can be increased of decreased depending on the conditions of perfusion. Acta Physiol. Scand., 126, 185-196.
40. 3H]nitrendipine binding sites in SHR and WKY rats, J. Cardiovasc. Pharmacol., 12 (Suppl. 4), S94-S97.
41. 2+ channels. Nat. Genet., 303, 535-537.
42. 2+-ATPase of sarcoplasimc reticulum. J. Biol. Chem., 264, 17816-17823.
43. SOMLYO, A.V., VIDAL, P. & SOMLYO, A.P. (1971). Excitation- contraction coupling and electrical events in two types of vascular smooth muscle. Microvasc. Res., 1, 354-373.
44. STUART, P.J., KLINE, R.L. & MERCER, P.F. (1979). Norepinephrine concentration in kidneys of normotensive Wistar-Kyoto and spontaneously hypertensive rats. Can. J. Physiol. Pharmacol., 57, 438-441.
45. + currents in guinea-pig smooth muscle cells. Br. J. Pharmacol., 107, 134-140.
46. TALLARIDA, R.J. & MURRAY, R.B. (1987). Manual of Pharmacologic Calculation with Computer Programs, 2nd edn, 132 p. Springer-Verlag, New York.
47. TSOPORIS, J. & LEENEN, F. (1988). Effect of arterial vasodilatators on cardiac hypertrophy and sympathetic activity in rats. Hypertens. Res., 11, 376-386.
48. 3H]norepinephrine release in hypothalamus of spontaneously hypertensive rats. Eur. J. Pharmacol., 194, 111-114.
49. VIDAL, M., HICKS, P.E. & LANGER, S.Z. (1986). Differential effects of α-β-methylene on SHR & WKY tail arteries. Naunyn Schiedebergs Arch. Pharmacol., 332, 384-390.
50. WADA, Y., SATOH, K. & TAIRA, N. (1985). Cardiovascular profile of Bay-K-8644, a presumed calcium channel activator in the dog. Naunyn Schmiedebergs Arch. Pharmacol., 328, 382-387.
51. WAKADE, A.R. (1981). Studies on secretion of catechol-amines evoked by acetylcholine or transmural stimulation of the rat adrenal gland. J. Physiol., 313, 463-480.
52. WARMINGTON, S.A., HARGREAVES, M. & WILLIAMS, D.A. (1996). A method for measuring sarcoplasmic reticulum calcium uptake in skeletal muscle using Fura-2. Cell. Calcium 20, 73-78.
53. YAMORI, Y. (1972). Organ difference of catecholamine metabolism in spontaneously hypertensive rats. In: Spontaneous Hypertension (Ed K. OKAMOT, pp. 59-61. Shoin Igaku, Tokyo.